Pediatric Multiple Sclerosis in the United Arab Emirates: Characteristics From a Multicenter Study and Global Comparison

Fatima Y. Ismail, Eliza Gordon-Lipkin, Katherine Huether, Iain Blair, Miklós Szólics, Taoufik Alsaadi, Faisal Aziz, Jehan Suleiman, Nicoline Schiess

Research output: Contribution to journalArticle

Abstract

We delineate the clinical characteristics, incidence, and prevalence of pediatric-onset multiple sclerosis in Abu Dhabi, United Arab Emirates, from 2010 to 2014. Eighty-two patients (65% female) were identified. Fifty-three (64.6%) were Emiratis (45 from Abu Dhabi and 8 from 5 other emirates) and 29 were expatriates. Mean age of onset was 15.9 years overall, 15.3 years in males and 16.3 years in females. Patients with onset before age 12 years presented with visual symptoms while those with onset after age 12 years presented with a mixture of visual, motor and sensory symptoms. Interferon beta-1a was the most frequently used disease-modifying therapy (48%). In Abu Dhabi Emirati nationals, the age- and sex-adjusted prevalences were 26/100 000 for males and 36/100 000 for females. The total incidence in Emirati nationals from 2010 to 2014 was 2.3/100 000 for ages 10 to 14 years and 7.2/100 000 for ages 15 to 19 years. By comparison with international cohorts, the incidence of pediatric-onset multiple sclerosis in Abu Dhabi is higher whereas gender distribution is similar.

Original languageEnglish (US)
Pages (from-to)422-427
Number of pages6
JournalJournal of Child Neurology
Volume33
Issue number6
DOIs
StatePublished - May 1 2018

Fingerprint

United Arab Emirates
Multicenter Studies
Multiple Sclerosis
Pediatrics
Age of Onset
Incidence

Keywords

  • children
  • epidemiology
  • multiple sclerosis
  • pediatrics
  • treatment

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology

Cite this

Pediatric Multiple Sclerosis in the United Arab Emirates : Characteristics From a Multicenter Study and Global Comparison. / Ismail, Fatima Y.; Gordon-Lipkin, Eliza; Huether, Katherine; Blair, Iain; Szólics, Miklós; Alsaadi, Taoufik; Aziz, Faisal; Suleiman, Jehan; Schiess, Nicoline.

In: Journal of Child Neurology, Vol. 33, No. 6, 01.05.2018, p. 422-427.

Research output: Contribution to journalArticle

Ismail, FY, Gordon-Lipkin, E, Huether, K, Blair, I, Szólics, M, Alsaadi, T, Aziz, F, Suleiman, J & Schiess, N 2018, 'Pediatric Multiple Sclerosis in the United Arab Emirates: Characteristics From a Multicenter Study and Global Comparison', Journal of Child Neurology, vol. 33, no. 6, pp. 422-427. https://doi.org/10.1177/0883073818759103
Ismail, Fatima Y. ; Gordon-Lipkin, Eliza ; Huether, Katherine ; Blair, Iain ; Szólics, Miklós ; Alsaadi, Taoufik ; Aziz, Faisal ; Suleiman, Jehan ; Schiess, Nicoline. / Pediatric Multiple Sclerosis in the United Arab Emirates : Characteristics From a Multicenter Study and Global Comparison. In: Journal of Child Neurology. 2018 ; Vol. 33, No. 6. pp. 422-427.
@article{b4a4f95939d54fcbbe9f35b9fe9a495d,
title = "Pediatric Multiple Sclerosis in the United Arab Emirates: Characteristics From a Multicenter Study and Global Comparison",
abstract = "We delineate the clinical characteristics, incidence, and prevalence of pediatric-onset multiple sclerosis in Abu Dhabi, United Arab Emirates, from 2010 to 2014. Eighty-two patients (65{\%} female) were identified. Fifty-three (64.6{\%}) were Emiratis (45 from Abu Dhabi and 8 from 5 other emirates) and 29 were expatriates. Mean age of onset was 15.9 years overall, 15.3 years in males and 16.3 years in females. Patients with onset before age 12 years presented with visual symptoms while those with onset after age 12 years presented with a mixture of visual, motor and sensory symptoms. Interferon beta-1a was the most frequently used disease-modifying therapy (48{\%}). In Abu Dhabi Emirati nationals, the age- and sex-adjusted prevalences were 26/100 000 for males and 36/100 000 for females. The total incidence in Emirati nationals from 2010 to 2014 was 2.3/100 000 for ages 10 to 14 years and 7.2/100 000 for ages 15 to 19 years. By comparison with international cohorts, the incidence of pediatric-onset multiple sclerosis in Abu Dhabi is higher whereas gender distribution is similar.",
keywords = "children, epidemiology, multiple sclerosis, pediatrics, treatment",
author = "Ismail, {Fatima Y.} and Eliza Gordon-Lipkin and Katherine Huether and Iain Blair and Mikl{\'o}s Sz{\'o}lics and Taoufik Alsaadi and Faisal Aziz and Jehan Suleiman and Nicoline Schiess",
year = "2018",
month = "5",
day = "1",
doi = "10.1177/0883073818759103",
language = "English (US)",
volume = "33",
pages = "422--427",
journal = "Journal of Child Neurology",
issn = "0883-0738",
publisher = "SAGE Publications Inc.",
number = "6",

}

TY - JOUR

T1 - Pediatric Multiple Sclerosis in the United Arab Emirates

T2 - Characteristics From a Multicenter Study and Global Comparison

AU - Ismail, Fatima Y.

AU - Gordon-Lipkin, Eliza

AU - Huether, Katherine

AU - Blair, Iain

AU - Szólics, Miklós

AU - Alsaadi, Taoufik

AU - Aziz, Faisal

AU - Suleiman, Jehan

AU - Schiess, Nicoline

PY - 2018/5/1

Y1 - 2018/5/1

N2 - We delineate the clinical characteristics, incidence, and prevalence of pediatric-onset multiple sclerosis in Abu Dhabi, United Arab Emirates, from 2010 to 2014. Eighty-two patients (65% female) were identified. Fifty-three (64.6%) were Emiratis (45 from Abu Dhabi and 8 from 5 other emirates) and 29 were expatriates. Mean age of onset was 15.9 years overall, 15.3 years in males and 16.3 years in females. Patients with onset before age 12 years presented with visual symptoms while those with onset after age 12 years presented with a mixture of visual, motor and sensory symptoms. Interferon beta-1a was the most frequently used disease-modifying therapy (48%). In Abu Dhabi Emirati nationals, the age- and sex-adjusted prevalences were 26/100 000 for males and 36/100 000 for females. The total incidence in Emirati nationals from 2010 to 2014 was 2.3/100 000 for ages 10 to 14 years and 7.2/100 000 for ages 15 to 19 years. By comparison with international cohorts, the incidence of pediatric-onset multiple sclerosis in Abu Dhabi is higher whereas gender distribution is similar.

AB - We delineate the clinical characteristics, incidence, and prevalence of pediatric-onset multiple sclerosis in Abu Dhabi, United Arab Emirates, from 2010 to 2014. Eighty-two patients (65% female) were identified. Fifty-three (64.6%) were Emiratis (45 from Abu Dhabi and 8 from 5 other emirates) and 29 were expatriates. Mean age of onset was 15.9 years overall, 15.3 years in males and 16.3 years in females. Patients with onset before age 12 years presented with visual symptoms while those with onset after age 12 years presented with a mixture of visual, motor and sensory symptoms. Interferon beta-1a was the most frequently used disease-modifying therapy (48%). In Abu Dhabi Emirati nationals, the age- and sex-adjusted prevalences were 26/100 000 for males and 36/100 000 for females. The total incidence in Emirati nationals from 2010 to 2014 was 2.3/100 000 for ages 10 to 14 years and 7.2/100 000 for ages 15 to 19 years. By comparison with international cohorts, the incidence of pediatric-onset multiple sclerosis in Abu Dhabi is higher whereas gender distribution is similar.

KW - children

KW - epidemiology

KW - multiple sclerosis

KW - pediatrics

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85045055227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045055227&partnerID=8YFLogxK

U2 - 10.1177/0883073818759103

DO - 10.1177/0883073818759103

M3 - Article

C2 - 29607711

AN - SCOPUS:85045055227

VL - 33

SP - 422

EP - 427

JO - Journal of Child Neurology

JF - Journal of Child Neurology

SN - 0883-0738

IS - 6

ER -